JDD in the Media

Why Melatonin Is Really Good for Your Skin

By April 29, 2020No Comments

Dermatology News

Featured Article

Melatonin is one of the latest trendy skincare ingredients that supposedly helps restore and improve skin tone, while helping to combat signs of aging.
While the hormone helps improve the body’s sleep and wake cycle, there has been evidence that it furnishes antioxidant properties that rival that of vitamin C and E.
Read Article Now

"Why Melatonin Is Really Good for Your Skin"

Melatonin is one of the latest trendy skincare ingredients that supposedly helps restore and improve skin tone, while helping to combat signs of aging.
While the hormone helps improve the body’s sleep and wake cycle, there has been evidence that it furnishes antioxidant properties that rival that of vitamin C and E.

Elle Magazine’s recent feature, “Why Melatonin Is Really Good for Your Skin” cites JDD research on the matter, “Assessing the Potential Role for Topical Melatonin as an Antiaging Skin Regimine.”

All day long, your skin encounters damaging free radicals, thanks to pollution and UV exposure. These face foes can alter the skin’s DNA, resulting in photo damage and even cancer, according to Lain. In order to neutralize free radicals, your body makes antioxidants, with the help of antioxidant enzymes. “Melatonin stimulates your body’s natural production of these enzymes,” says Dr Engelman. And, according to a study published in the Journal of Drugs in Dermatology, these melatonin-induced antioxidants are more effective than those from the ever-popular vitamins C and E.

Melatonin works in concert with more common anti-aging ingredients to increase antioxidant levels, and dermal applications don’t seem to affect energy levels.

Learn more about Melatonin’s use in anti-aging skin regimens – check out the article here.

Read Article Now
JDD Article Referenced in this Post

You May Also Like

AcneFeatured ArticlesLatest NewsThe Latest
September 25, 2025

From the Vault: Integrated Short-Term and Long-Term Efficacy of Topical Clascoterone Cream 1% in Patients Aged 12 Years or Older With Acne Vulgaris

Clascoterone Keeps Gaining Ground in Acne Two identical Phase 3 trials (plus a long‑term extension) randomized patients ≥12 years with moderate‑to‑severe acne to twice‑daily clascoterone 1% cream or vehicle for…
Journal of Drugs in Dermatology JDD Article About Microneedling Combined With Drugs and Stem Cells for Treating Androgenetic AlopeciaAlopeciaFeatured ArticlesLatest NewsThe Latest
September 24, 2025

Microneedling Combined With Drugs and Stem Cells for Treating Androgenetic Alopecia

Small Channels, Smarter Delivery -  A Practical Boost For Topical And Regenerative Approaches Microneedling is proving to be a low‑risk, clinic-friendly way to enhance topical therapies (most consistently 5% minoxidil, now…
Journal of Drugs in Dermatology JDD Article About The Prevalence of Dupilumab-Associated Adverse Events Among Black and African American Adult Patients With Atopic Dermatitis: A Retrospective Chart ReviewAtopic DermatitisFeatured ArticlesLatest NewsThe Latest
September 24, 2025

The Prevalence of Dupilumab-Associated Adverse Events Among Black and African American Adult Patients With Atopic Dermatitis: A Retrospective Chart Review

Dupilumab in Diverse Skin — Are Adverse Events Really the Same? Atopic dermatitis isn’t one-size-fits-all: chronic type 2 inflammation, barrier dysfunction, and S. aureus colonization are core features, but presentation…

Leave a Reply